Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read MoreThe results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that
Read MoreAnti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read More2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read MoreGLP-1 medications could have far-reaching implications for a wide variety of conditions, from liver disease to sleep apnea to heart
Read MoreHere are the biggest calls on Wall Street on Source link
Read More